Brown Advisory Securities’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-275,000
Closed -$1.2M 287
2021
Q2
$1.2M Hold
275,000
0.19% 84
2021
Q1
$1.13M Hold
275,000
0.19% 85
2020
Q4
$1.1M Hold
275,000
0.19% 83
2020
Q3
$743K Hold
275,000
0.15% 98
2020
Q2
$729K Hold
275,000
0.16% 95
2020
Q1
$624K Hold
275,000
0.16% 107
2019
Q4
$1.29M Hold
275,000
0.31% 75
2019
Q3
$920K Hold
275,000
0.26% 83
2019
Q2
$905K Hold
275,000
0.24% 85
2019
Q1
$833K Hold
275,000
0.2% 105
2018
Q4
$781K Hold
275,000
0.15% 135
2018
Q3
$924K Hold
275,000
0.15% 136
2018
Q2
$710K Hold
275,000
0.12% 174
2018
Q1
$605K Hold
275,000
0.11% 178
2017
Q4
$547K Hold
275,000
0.11% 191
2017
Q3
$891K Hold
275,000
0.19% 119
2017
Q2
$886K Hold
275,000
0.2% 115
2017
Q1
$781K Hold
275,000
0.19% 123
2016
Q4
$641K Hold
275,000
0.17% 130
2016
Q3
$462K Buy
+275,000
New +$337K 0.13% 177
2015
Q4
Sell
-27,587
Closed -$47K 317
2015
Q3
$47K Hold
27,587
0.02% 274
2015
Q2
$57K Sell
27,587
-550
-2% -$1.33K 0.02% 290
2015
Q1
$76K Hold
28,137
0.03% 282
2014
Q4
$72K Hold
28,137
0.03% 260
2014
Q3
$51K Sell
28,137
-22,413
-44% -$48.9K 0.02% 266
2014
Q2
$135K Hold
50,550
0.05% 271
2014
Q1
$177K Hold
50,550
0.07% 247
2013
Q4
$226K Hold
50,550
0.09% 219
2013
Q3
$205K Hold
50,550
0.09% 228
2013
Q2
$210K Buy
+50,550
New +$195K 0.1% 205

Other funds holding ATRS

Brown Advisory Securities's ATRS Position: Q3 2021 in Review

Brown Advisory Securities sold out of Antares Pharma, Inc. (ATRS) in Q3 2021, closing a stake of 275,000 shares — an estimated $1.2M sold.

Brown Advisory Securities first reported a position in ATRS in Q2 2013 and held it in 30 quarters. The position peaked at $1.29M in Q4 2019. 170 funds tracked by Wall St. Rank hold ATRS as of Q3 2021.

  • Brown Advisory Securities reported no remaining Antares Pharma, Inc. position as of Q3 2021 after selling out during the quarter.
  • Brown Advisory Securities sold 275,000 Antares Pharma, Inc. shares in Q3 2021, an estimated $1.2M.
  • Brown Advisory Securities first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 30 quarters.
  • Brown Advisory Securities's Antares Pharma, Inc. position peaked at $1.29M in Q4 2019.
  • 170 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2021.

Based on Brown Advisory Securities's 13F filing for Q3 2021, filed 12 Nov 2021.